Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Levofloxacin (125mg/5ml) + Ornidazole (125mg/5ml)
Therapeutic Category
Antibacterials, Antibiotic, Antidiarrheal, General and OTC medicines, Gastroenterology
Dosage Form
Suspension
Packaging Type
with Outer with Measuring Cap
Packaging
30ml
Price
₹83/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Lexoziff OZ Suspension is a broad-spectrum antimicrobial formulation combining Levofloxacin (125mg/5ml) and Ornidazole (125mg/5ml). This dual-action suspension is designed to effectively target a wide range of bacterial and protozoal infections, particularly those affecting the gastrointestinal and respiratory systems.
This combination is particularly useful for mixed infections, providing a synergistic action against both aerobic and anaerobic pathogens. Lexoziff O Suspension is ideal for pediatric and adult patients requiring precise and effective treatment for infections.
Common side effects may include nausea, diarrhea, dizziness, headache, or abdominal discomfort. Rarely, allergic reactions or photosensitivity may occur.
Lexoziff OZ Suspension is indicated for treating mixed bacterial and protozoal infections, including diarrhea, dysentery, respiratory infections, and other systemic infections caused by susceptible organisms.
Use Lexoziff OZ Suspension only under the guidance of a healthcare professional. Complete the full course of treatment to prevent resistance. Avoid usage in patients with a known allergy to quinolones or nitroimidazole derivatives.
Store in a cool, dry place below 30°C. Protect from light and moisture. Keep out of reach of children. Shake well before use.
Composition : Azithromycin (100mg/5ml) Suspension
Composition : Ofloxacin (50mg) + Ornidazole (125mg) + Racecadotril (15mg)
Composition : Ofloxacin (50mg/5ml)
Composition : Azithromycin (200mg) Suspension
Composition : Rifaximin (100mg/5ml)
Composition : Amoxycillin (250mg) + Clavulanic Acid (50mg)
Composition : Amoxycillin (500mg) + Clavulanic Acid (100mg)
Composition : Amoxycillin (1000mg) + Clavulanic Acid (200mg)
Composition : Amoxycillin (125mg) + Clavulanic Acid (25mg)
Composition : Azithromycin (500mg) Injection
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination suspension is used for bacterial and protozoal infections, including gastrointestinal infections, diarrhea, dysentery, and mixed infections. It is a strong anti-infective and gastrointestinal segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in pediatric and general practice prescriptions, especially for acute infections. It is widely used by general physicians for gastrointestinal and mixed bacterial-protozoal infections, ensuring strong seasonal and routine demand.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for anti-infective and gastrointestinal formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from high prescription volume, acute care demand, pediatric usage, and repeat purchases in infection-related treatments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this anti-infective formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.